Cue Biopharma is working at the cutting edge of the immunotherapy revolution, with the potential to offer patients significant therapeutic advantages while minimizing or eliminating unwanted side effects. Our goal is to develop and bring to market biologics that can overcome the challenges faced by prevailing immunotherapeutics, via direct engagement with and modulation of disease-associated T cells in a patient’s body.

CUE pipeline